Table 4.

Acceptable upper limit of vitamin D intake stated by various health bodies.^*

Age	ESPG	SACN	IOM	EFSA
Infant	0–6 m: 1000 IU (25 μg)/d	1000 IU (25 μg)/d	0–6 m: 1000 IU (25 μg)/d	1000 IU (25 μg)/d
	6–12 m: 1500 IU (37.5 μg)/d		6–12 m: 1500 IU (37.5 μg)/d
1–10 y	1–3 y: 2500 IU (62.5 μg)/d	2000 IU (50 μg)/d	1–3 y: 2500 IU (62.5 μg)/d	2000 IU (50 μg)/d (children and adolescents)
	4–8 y: 3000 IU (75 μg)/d		4–8 y: 3000 IU (75 μg)/d
11–17 y	>8 y: 4000 IU (100 μg)/d	4000 IU (100 μg)/d	9–18 y: 4000 IU (100 μg)/d
Adult	4000 IU (100 μg)/d	4000 IU (100 μg)/d	19->70 y: 4000 IU (100 μg)/d	4000 IU (100 μg)/d

^*The upper limit did not apply to individuals with certain medical conditions such as normocalcaemic hyperparathyroidism and granulomatous conditions (sarcoidosis and tuberculosis) which predispose to hypercalcaemia, or to those with genetic conditions such as familial hypocalciuric hypercalcaemia.

ESPG, Endocrine Society Practice Guideline; SACN, Scientific Advisory Committee on Nutrition; IOM, Institute of Medicine; EFSA, European Food Safety Authority.